Akoustis Technologies Inc expected to post a loss of 20cents a share - Earnings Preview

Aktis Oncology

28/01/2022 12:09

* Akoustis Technologies Inc  AKTS.OQ   AKTS.O  is expected
to show
a rise in quarterly revenue when it reports  results on January
31. 
    * The Huntersville North Carolina-based  company is expected
to
report  a 188.9% increase in revenue to $3.778 million from
$1.31 million a year ago, according to the mean estimate from 4
analysts, based on Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for Akoustis
Technologies Inc
is for a loss of 20 cents per share. For the same quarter last
year, the company reported a loss of 22 cents per share.
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 4 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Akoustis
Technologies Inc is $14.5​, about 66.6% above​ its last closing
price of $4.84. ​​​
    * 

This summary was machine generated January 28 at 12:09 GMT.  All
figures in US dollars  unless otherwise stated